Witness of tuberculosis: lipoarabinomannan antigen

L. A. Henn, E. A. Almeida (Porto Alegre, Brazil)

Source: Annual Congress 2004 - Diagnostic clinical and biological features in tuberculosis
Session: Diagnostic clinical and biological features in tuberculosis
Session type: Poster Discussion
Number: 342
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. A. Henn, E. A. Almeida (Porto Alegre, Brazil). Witness of tuberculosis: lipoarabinomannan antigen. Eur Respir J 2004; 24: Suppl. 48, 342

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Biomarkers for tuberculosis: the case for lipoarabinomannan
Source: ERJ Open Res, 5 (1) 00115-2018; 10.1183/23120541.00115-2018
Year: 2019



Evaluation of a IFN-γ test using Mycobacterium tuberculosis-specific antigens for diagnosis of active tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 142s
Year: 2006

Usefulness of serum glycopeptidolipid core immunoglobulin A antibody in mycobacterium avium complex infection
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014


Clinical evaluation of glycopeptidolipid core antigen IgA antibodies for serodiagnosis of mycobacterium avium complex disease
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015

Humoral immune response against mycobacterial antigens 38kDa and lipoarabinomannan (LAM) in extrapulmonary tuberculosis (EXTB) in adults and children
Source: Eur Respir J 2003; 22: Suppl. 45, 341s
Year: 2003

Clinical evaluation of glycopeptidolipid core antigen IgA antibodies for serodiagnosis of mycobacterium avium complex pulmonary disease
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013

Capacities of blood serum lipoarabinomannan in the diagnosis of tuberculosis at a late stage of HIV infection
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018

Tuberculosis treatment effect on T-cell interferon-γ responses to Mycobacterium tuberculosis-specific antigens
Source: Eur Respir J 2010; 36: 355
Year: 2010



Discriminating active from latent tuberculosis by Mycobacterium tuberculosis (MTB)-peptide specific immunoresponses
Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET)
Year: 2008


Comparison of T-cell interferon-γ release assay to mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009


Role of detection of lipoarabinomannan (LAM) in urine for diagnosis of tuberculosis in HIV patients; Egyptian experience
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017

Deficient in silico selection of mycobacterium tuberculosis (MTB) epitopes in tuberculosis (TB) patients
Source: Eur Respir J 2006; 28: Suppl. 50, 801s
Year: 2006

Serodiagnosis of mycobacterium avium-complex pulmonary disease using anti-glycopeptidolipid core antigen IgA antibody
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


IGG immune response against MPT-64, CFP-10 and ESAT-6 antigens in children with pulmonary tuberculosis
Source: Annual Congress 2009 - Diagnostic tools in paediatric respiratory infection
Year: 2009



Unique cytokine profiles of CD4+T cell to Acr, HBHA and MDP-1 antigens in different clinical stage of mycobacterium tuberculosis infection
Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection
Year: 2014

Clinical nalysis of glycopeptidolipid core antigen IgA antibodies for cases in which it is difficult to obtain a definite diagnosis of mycobacterium avium complex pulmonary disease
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016

Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008


Comparison of serum anti-tuberculous glycolipid antigen antibodies among the patients of tuberculous and nontuberculous pulmonary diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 340s
Year: 2001

Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection
Source: Eur Respir J 2006; 28: 24-30
Year: 2006



Quantitative T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens in latent and active tuberculosis
Source: Annual Congress 2008 - New tools in tuberculosis diagnosis
Year: 2008